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Abstract
CHARACTERIZATION OF PIEZO2 INVOLVEMENT IN STRESS-INDUCED
ALTERATIONS TO GI FUNCTION AND NOCICEPTION

By Cristina Smith, M.S.
A Thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
in Physiology and Biophysics at Virginia Commonwealth University.
Virginia Commonwealth University, 2022

Professor: Dr. Liya Qiao, PhD
VCU School of Medicine
Physiology and Biophysics

Irritable Bowel Syndrome (IBS) is a functional gastrointestinal (GI) disorder marked by visceral
hypersensitivity and changes in bowel function. Visceral sensation is initiated in the dorsal root
ganglia (DRG) by primary afferent nerves that detect and transduce chemical and mechanical
stimuli into electrical signals which relay to the central nervous system (CNS). The aim of this
investigation was to characterize the role of Piezo2, a mechanically sensitive ion channel, located
in nociceptive sensory afferents in the regulation of GI function in mice subjected to Water
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Avoidance Stress (WAS). Initially, body weight growth, colonic transit time, and somatic von
Frey filament testing were used to characterize baseline changes in male and female mice after
Piezo2 knockout from nociceptive afferent neurons (Piezo2cKO) and compared to Piezo2 intact
(Piezo2wt) mice. Piezo2cKO had a sex-dependent impact on GI function and mechanical
sensitivity that impacted sensory homeostasis of female, but not male mice. Therefore, male
mice were further tested for the role of Piezo2 in an animal model of WAS: WAS increased
somatic mechanical sensitivity, slowed colonic transit time, and altered gait and stride patterns.
Piezo2cKO attenuated WAS-induced somatic hypersensitivity and exacerbated WAS-induced
reduction in colonic transit, but had no significant impact on WAS-induced sensory dysfunction
assessed by gait assay. The expression of calcitonin gene-related peptide (CGRP) in DRG
neurons was also increased by WAS in Piezo2wt mice, but not Piezo2cKO mice. These findings
suggest Piezo2, in nociceptive neurons, plays a role in the modulation of visceral and somatic
mechanosensitivity in a sex-dependent manner and participates in stress-induced GI dysfunction.
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Introduction
1.1 Irritable Bowel Syndrome
Irritable bowel syndrome is one of several functional gastrointestinal (GI) disorders prevalent
throughout the United States and the world. According to the American College of
Gastroenterology, in the United States IBS is common with incidents ranging from 10-15% of
the population. Direct medical costs, not including prescription and over the counter drugs, are
estimated to be up to $10 billion annually. Furthermore, surveys completed in the US and UK
indicate individuals miss an average of 8.5 and 21.6 days per year from work due to IBS
symptoms 54. IBS is the most common disorder seen by gastroenterologists 48 and the most
common GI disorder seen in primary care 76. Clinical symptoms include abdominal pain,
bloating, and altered bowel function; however, there is a distinct lack of structural abnormalities
seen in the GI tract. IBS is often associated with comordities including somatic pain and
psychological conditions. Risk factors include age, gender, genetics, preceding GI infection,
psychiatric disorders, and stressful life events. The best treatment for IBS is an individualized
treatment plan based on symptoms using a holistic approach that address diet, lifestyle, and
medical and behavioral interventions 23.
IBS is a condition of the lower GI tract with three subtypes based on bowel function: IBSConstipation (IBS-C), IBS-Diarrhea (IBS-D), and IBS-Mixed. Unlike other functional GI
disorders there is no biomarker or laboratory test for IBS; diagnosis is based on symptoms and
rule out of other diseases. There is also no cure for IBS with many patients experiencing cycles
of remission and symptom flare ups. The pathophysiology of IBS is complex. Its cause and
underlying mechanisms are not easily characterized; however, hallmarks of the disorder include

visceral hypersensitivity, altered bowel motility, neurotransmitters imbalance, and psychosocial
factors. The occurrence and diagnosis of IBS is more common in women 1 with gender being a
significant risk factor for the development of IBS 31. Gender differences have been observed in
regard to GI function including transit time, perception of visceral pain, brain activation patterns,
and colonic mucosal immune activation 1 all of which contribute to the greater prevalence of IBS
symptoms in women.
IBS is considered a disorder of gut-brain interaction. The transmission of sensation from the
lower GI tract to the central nervous system (CNS) allowing the gut to communicate with the
brain is known as the “gut-brain axis” 14. Maintaining homeostasis within this bidirectional
signaling system is essential for maintaining healthy gut function. Under homeostatic conditions
intestinal content exert mechanical forces against the walls of the gut. Mechanosensation of these
stimuli allow the brain to derive information on the location, amount, and mechanical properties
of content such as stool. Abnormally increased mechanosensitivity may cause irritation or
painful sensations in individuals 45. Lower threshold for colonic pain is observed in most patients
with IBS compared to healthy patients 11. The gut-brain axis is distorted in nearly all patients
with IBS as they present with visceral hypersensitivity that has been attributed to dysfunctional
mechanosensation 58.

1.2 Visceral Pain and Hypersensitivity
The physiology of sensation involves extrinsic primary afferent nerves responsible for
sensing visceral and somatic stimuli and transducing those sensations from the peripheral
nervous system (PNS) to the CNS. Primary afferents are the first in a chain of neurons that give
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rise to the conscious sensation of pain. They
synapse with higher order neurons in the spinal
cord and brainstem to relay signals to deeper
sensory neurons in the CNS. Central processing
is critical for determining how a stimulus will be
perceived. Cell bodies (soma) of afferent neurons
are located in dorsal root ganglia (DRG). These
neurons are pseudounipolar with one end of the
bifurcated axon innervating peripheral tissue
and the other synapsing with CNS structures.
DRG only contain sensory neurons; however,

Figure 1. Projection of primary afferents to visceral
organs and relay to second order neurons in the
spinal cord. Cell bodies of primary afferent neurons are
located in DRG, their axons are pseudounipolar with one
end innervating peripheral tissue and the other synapsing
with CNS structures.

the neuron population is heterogenous detecting proprioception, thermoception, mechanoception,
and nociception 73.
Visceral pain is defined as pain arising from internal organs 19. Pain sensation is associated
with the activation of receptors in the aforementioned primary afferents, specifically those
associated with unmyelinated C-fiber and myelinated Aσ-fibers nociceptive neurons. Visceral
pain is often diffuse and poorly localized with pain felt at sites distant from the internal organ,
known as referred pain. IBS is increasingly recognized to have concurrent somatic pain; one
suggested underlying mechanism is cross-organ sensitization occurring in the DRG where
colonic afferent neurons convey nociceptive information to activate primary afferents
innervating distant organs 64. Furthermore, visceral afferents demonstrate extensive divergence
and intraspinal distribution compared to somatic afferents 32. Sensory neurons innervating large
areas of a given organ branch within the spinal dorsal horn to connect to many second order

3

neurons. Convergence of visceral and somatic inputs onto a common secondary neuron can lead
to referred pain 18.
Visceral hypersensitivity is the hallmark symptom of functional GI disorders like IBS.
Produced by persistent noxious stimuli 70, visceral hypersensitivity includes both hyperalgesia,
increased response to painful stimuli, and allodynia, painful response to innocuous stimuli 67. In
IBS, visceral hypersensitivity is typically seen in the colon and rectum with colorectal pain
usually stimulated by mechanical distention and stretch mechanosensation 29. In the clinical
setting, colorectal distension (CRD) can be used to determine visceral hypersensitivity. During
testing a balloon is inserted into the distal colon or rectum and then inflated with increasing
pressures or volumes to stimulate sensory afferent nerves. Each distention is graded for
perceived pain. IBS patients report significantly lower pain thresholds and higher pain scores,
with some studies reporting 35-90% of IBS patients demonstrated visceral hypersensitivity 25.
Patients who experience functional pain disorders such as IBS can also experience somatic
mechanical hyperalgesia along with visceral hyperalgesia. However, visceral and somatic
mechanical hyperalgesia require different stimuli. Somatic mechanosensing is elicited by cutting,
pinching, or piercing while visceral mechanosensation responds to spontaneous stimulation such
as distension and stretch. Animal models and human studies often assess both when studying
visceral hypersensitivity.
Visceral sensory afferents act to maintain many aspects of GI physiology. Sensory afferents
innervating the GI tract detect physical and chemical stimuli and project to the CNS through
autonomic and sympathetic nerves, known as dual sensory innervation 70. GI afferents are
segmental based on the location of their cell bodies in DRG and travel along with splanchnic
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nerves (part of sympathetic innervation) which terminate in thoracolumbar spinal regions as well
as vagal and pelvic nerves (part of parasympathetic innervation) which terminate in lumbosacral
spinal regions. The GI tract is also intrinsically innervated by the enteric nervous system (ENS)
that coordinates with extrinsic neurons to regulate GI function. Once excited, extrinsic sensory
pathways of the colon and rectum provide direct contact with the CNS contributing to the
generation of perceivable sensations, including pain 15.
GI motility or peristalsis is transduced by mechanosensitive afferents. Functional
classifications of colonic afferents are divided into the following five classes defined by their
functional properties: muscular afferents that respond to stretching of the colon, mucosal
afferents that respond to light distortion of the mucosa, muscular/mucosal afferents that respond
to stretch as well as light distortion of the mucosa, vascular afferents (including serosal and
mesenteric) that respond to probing of the colon wall, and “silent” mechanically insensitive
afferents that respond to chemical stimuli, but can be sensitized to detect mechanical stimuli
16

14,

. These five class have been demonstrated in both rodents and humans 40. Muscular afferents

include both low-threshold mechanoreceptors (LTMR) that respond to low-intensity stretch
stimuli and high threshold mechanoreceptors each with dedicated nociceptors 43,53. Mucosal
afferents that exhibit only low threshold mechanosensors are thought to participate in defecatory
reflexes 15. Vascular afferents are high-threshold mechanosensors that display an adaptive
response to noxious stimuli 14. Both low and high threshold mechanosensors are implicated in
visceral pain sensation and classification of colonic afferents continue to be updated with
additional characterizations based on molecular profiles including peptidergic and nonpeptidergic 42 and voltage-gated sodium channel expressing nociceptors such as those expressing
Nav1.8 9.
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1.3 Piezo2 and Mechanosensing
Discovered in 2010 by Dr. Ardem Patapoutian and colleagues at The Scripps Research
Institute, California, Piezo1 and Piezo2, represent an entirely new class of vertebrate
mechanosensitive channels. The groundbreaking discovery of Piezo proteins won Patapoutian the
Nobel Prize in Physiology or Medicine in 2021. Named for the Greek word “piesi,” meaning
pressure, Piezo proteins exist in two isoforms, Piezo1 and Piezo2. The two isoforms are large
proteins and lack any resemblance to previously identified ion channels. Piezo2, for instance,
contains thirty-eight transmembrane domains; the most of any known membrane protein 80.
Discovery of piezo proteins as excitatory ion channels gated by mechanical force
provided the molecular basis for mechanosensation in mammals. Mechanosensation not only
includes touch, but proprioception and unconscious regulation of visceral functions such as heart
rate, breathing, and peristalsis (visceroception). The key step in mechanosensation is
mechanotransduction where molecules expressed in mechanoreceptors undergo conformational
changes in response to mechanical stimuli converting forces into electrochemical signals 78.
Piezo2 is a nonselective cation channel found to be highly enriched in DRG neurons, while
Piezo1 has low expression in sensory ganglia. For neurons in the DRG expressing Piezo2 an
influx of cations in response to mechanical force is excitatory acting to depolarize the membrane
and trigger action potentials 73. Piezo2 knockout and knock-down studies in rodents and human
loss of function mutations have shown Piezo2 is an essential mechanotransducer for touch,
proprioception, and visceroception 56, 74, 85, 88. Piezo2 is present in all known LTMRs including
those of GI afferents and select types of nociceptors 75. Piezo2’s expression in small diameter
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nociceptors 24 and colonic afferents coexpressing Nav1.8 63 suggest the potential role of Piezo2 in
noxious mechanosensation. Piezo2 is also expressed in innocuous large diameter myelinated
mechanoreceptors 51 suggesting it also plays a role in innocuous mechanosensation and
proprioception.
Many GI tract functions require mechanosensory information and Piezo2 is located
throughout the lower GI system. Piezo2 is expressed in enterochromaffin cells of the GI
epithelium and modulates serotonin secretion in response to mechanical stimuli 2,79 as well as
myenteric and sensory neurons 47, 40. Notable GI disorders that involve altered
mechanotransduction include inflammatory bowel diseases like ulcerative colitis and Crohn’s
disease, IBS and visceral hypersensitivity, and systemic conditions like obesity 44. Transcriptome
profiling of colon-projecting DRG neurons in mice have revealed Piezo2’s wide expression
among a diverse population of sensory neurons targeting the lower GI tract 40. The role of Piezo2
in these sensory neurons is an exciting and active area of study. Murthy et al. 56 demonstrated
through knockout studies that Piezo2 may mediate mechanically activated currents in calcitonin
gene-related peptide (CGRP) expressing nociceptor neurons in cultured DRG. Results revealed a
decrease in mechanosensation of these nociceptor neurons highlighting that Piezo2 plays a role
in nociception. Yang et al. 85 showed that reduced expression of Piezo2 in lumbosacral DRG,
known to innervate the colon, attenuated visceral sensation to innocuous and noxious stimuli in
whole rat models suggesting the role of Piezo2 in the mediation of visceral sensation.
Piezo2 has been difficult to study in humans due to the rarity of Piezo2 deficiency
syndrome and lack of accessibility to Piezo2-rich human tissue such as DRG. However, exciting
human stem cell research has resulted in the generation Piezo2 loss of function sensory-like
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neurons insensitive to mechanical stimuli and may provide a future framework for novel disease
models of touch and pain 57. At present, most proposed approaches for the study of Piezo2 using
whole animal models include using a conditional knockout where cell-type-specific promoters
driving Cre recombinase allow for the elimination of Piezo2 in subsets of cells 56. Complete loss
of function in murine models results in mortality at birth due to Piezo2’s essential role in
respiration.

1.4 Nav1.8 Channels
Involvement of additional ion channels concerning visceral hypersensitivity is noteworthy in IBS
models. Nav channels play a central role in neurotransmission of nociceptive signaling in DRG
sensory neurons and are preferentially expressed in the PNS 27. They are crucial to the generation
and conduction of action potentials and therefore excitability of sensory neurons 84. The Nav1.8
isoform is one of the most abundant sodium channels in mouse lumbar DRG 20. It is also highly
expressed in colonic afferent neurons with an expression level of about 96% in the
thoracolumbar segments and 91% in lumbosacral segments 42. In mice, the Nav1.8 channel is
tetrodotoxin-resistant and expressed in colonic afferent neurons 9,27, by unmyelinated smalldiameter nociceptors, and myelinated LTMRs 69. Previous work by our lab has demonstrated that
Peizo2-IR was found in nociceptive DRG neurons expressing Nav1.8 channel. Nav channels are
secondary in the neuronal response to stimuli, they regulate neuronal excitability and amplify
cation influx generated by primary transducers 20,46 such as Piezo2 to generate and propagate
action potential.

8

1.5 Calcitonin-Gene Related Peptide
Calcitonin-gene related peptide (CGRP) is a 37 amino-acid neuropeptide 3 produced
primarily by primary afferent nerves of the PNS and released to CNS. It is an important
neuromodulator and nociceptive marker participating in nociceptive pain perception 78. CGRP is
highly expressed by small to medium diameter primary afferent neurons of the trigeminal
ganglion and DRG 39. Neuropeptides are thought to mediate visceral nociceptive signals from
peripheral to central pathways via spinal central sensitization 65. Local neuropeptides such as
CGRP are well known to be secreted by nociceptive neurons and act as slow neurotransmitters,
they lead to the experience of tonic pain whereas other neurotransmitters like glutamate and
aspartate evoke sharp and fast pain when released synaptically 88. Perhaps most notably, CGRP
has been implicated in migraine pathophysiology. CGRP infusions induce headaches in patients
suffering from migraines 38 while CGRP receptor inhibition has been shown to be an effective
therapeutic for migraines 21. Interestingly, migraine pain has recently been associated with
mechanical hypersensitivity, suggesting enhanced mechanotransduction. Studies have pointed to
Piezo1 and Piezo2 as the vascular and neuronal sensors of intracranial mechanical forces
respectively and presented Piezo channels as potential players in meningeal nociception and
migraine. Mechanosensitive mechanisms can underlie the worst migraine symptoms such as
mechanical hyperalgesia and pulsating pain 61.
In the GI tract, CGRP is an important factor in GI physiology and pathophysiology 28, for
example release of CGRP from colonic afferents has been shown to cause vasodilation and
exacerbate inflammatory processes seen in irritable bowel disease (IBD) 49. Additionally, CGRPimmunoreactive nerve density was shown to be significantly increased in rat primary afferent
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pathways following 2,4,6-trinitrobenzene sulfonic acid (TNBS) induced colitis 37,65.
Furthermore, using a model of stress-induced colonic hypersensitivity Noor-Mohammad et al.
demonstrated that a peripheral CGRP blockade attenuates colonic hypersensitivity and inhibits
neuronal activation in the dorsal horn of the thoracolumbar spinal cord in response to noxious
colonic distension 59.

1.6 Stress and Visceral Pain
Stress and pain are both adaptive protective processes; however, in their chronic states
they can lead to long term maladaptive alterations to physiology. It is well documented that
stress contributes to IBS symptoms and psychiatric comorbidities are prevalent in patients with
IBS 30,48. A history of childhood trauma 39 and stressful life events are known risk factors for IBS
50

. Colonic afferent nerve sensitization and increased pain signaling to the brain serve as a

bottom-up, gut to brain, processing of model of visceral pain. Afferent pathways affect neuronal
activity and neurotransmitter release in areas of the brain involved in stress, emotion, and
visceral pain processing 7. Examining things from a top-down model, stress can promote
maladaptive GI function and contribute to pain processes. As a result of sensitized primary
afferents, it is likely that remodeling of ascending afferents in the dorsal horn occurs followed by
hyperactivity of central pain circuitry in the brain, and/or loss of descending inhibition 55.
In mammals there are two stress response pathways: the hypothalamic-pituitary-adrenal
(HPA) and sympathomedullary axes 55. Acute stress activates the sympathetic nervous system
releasing epinephrine and norepinephrine diverting blood flow away from the GI tract toward
muscles necessary for quick “fight or flight” responses. Pain perception is also diminished during
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this time. Chronic stress on the other hand, challenges the body’s homeostasis and plays a major
role in the onset, maintenance, and exacerbation of IBS symptoms by triggering HPA
dysregulation and sympatoneuronal outflow into DRG 68. Habituation to repeated stressors as
seen with the acute stress is beneficial and adaptive; it can limit the occurrence and severity of
stress-related symptoms including stress-induced alterations of GI transit. However, chronic
stress has been associated with sympathetic signals spreading to the periphery as demonstrated
by Xia et al. where sympathetic nerve sprouting into thoracolumbar DRG occurred in rats
following TNBS-induced colitis 83. Sympathetic influence on sensory afferents can further
contribute to hypersensitivity as Zhang et al. demonstrated using a rat model of stress-induced
visceral hypersensitivity where hypersensitivity was attenuated by administering a non-selective
b-adrenergic antagonist 86.

1.7 Animal Model of IBS
Many aspects of the pathogenesis of functional GI diseases cannot be performed in
humans, therefore reliable animal models are needed. Preclinical trials using rat and mice models
have demonstrated significant GI dysfunction and hypersensitivity to CRD by sensitizing colon
primary afferent neurons as a result of chronic stress 13,22. Murine studies of repeated water
avoidance stress (WAS), a well-established chronic stress model, have been shown to alter
stimulus-evoked neuronal activation and nociceptive signaling pathways 4,28,36 and lead to sustain
visceral hypersensitivity 13 providing an effective animal mode of IBS.
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Objective and Aims

Objective
This study seeks to examine whether the mechanosensitive ion channel Piezo2 plays a role in
regulating GI function and pain response in stressed mice.

Hypothesis
Piezo2 in nociceptive neurons mediates GI function and dysfunction in mice subjected to a
stress-induced IBS model.

Aims:
1. Characterize the baseline function of male and female mice after Piezo2 knockout –
comparison of GI function and somatic responses to mechanical stimuli in Piezo2wt and
Piezo2cKO mice.
2. Characterize Peizo2 as a player in stress-induced alterations in GI function and response to
mechanical stimuli.
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Research Design and Methods
3.1 Research Design
3.1.1 Baseline Characterization of GI function and somatic sensitivity
Male and female Piezo2wt and Piezo2cKO mice were assessed for GI function, body weight
growth and colonic transit time, as well as somatic mechanical sensitivity using von Frey testing
(Figure 2A). Age-matched mice were used for comparison.

3.1.2 Characterization of WAS-induced alterations to GI function and mechanical
sensitivity
Male Piezo2wt and Piezo2cKO animals between the ages of eight to twelve weeks were
subjected to a four-day course of WAS4. Age-matched mice were used as experimental groups
for comparison. On day four, animals were assessed for GI function (colonic transit) and
mechanosensation (von Frey testing and stride assay) (Figures 2B, 3,4,5). CGRP protein analysis
was also conducted using explanted DRGs (Figures 11 and 12).

3.2 Methods and Materials
Experimental Animals
Male and female adult Black C57BL/6 mice were used for all studies. Standard
husbandry conditions with 12:12-h light cycles and free access to regular food/water were
provided to each cage that housed 2–5 mice to ensure adequate social environment. All
experimental protocols involving animal use were approved by the Institutional Animal Care and
Use Committee at the Virginia Commonwealth University. Animal Care was in accordance with
the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and
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National Institutes of Health (NIH) guidelines. All efforts were made to minimize the potential
for animal pain or distress as well as to reduce the number of animals used.

Transgenic animals
Piezo2cKO mice were generated by using Nav1.8-Cre+/+ mice and floxed Piezo2
(Piezo2fl/fl) mice (JAX Stock # 027720). Piezo2wt mice were generated by crossing Nav1.8-Cre+/+
mice with wildtype mice.

Body Weight Growth
Animals were weighed at the time of weaning (three weeks or post-natal day 21) and then
every seven days thereafter until body weight plateaued at seven weeks.

Colonic Transit
Under light anesthesia (1-2 % isoflurane), a 3 mm-diameter glass bead (Sigma-Aldrich, St.
Louis, MO) was inserted 3 cm into the distal colon following prior established protocols 66. A PE100 catheter with a lightly flared end was used to advance the beads. The catheter was then
withdrawn and the animal was immediately placed into a glass chamber for recovery. Total transit
time was measured starting as soon as the catheter was removed and stopped when the bead was
expelled out. Animals were tested in the afternoon sessions between 1-3pm.

Von Frey
Following the simplified up-down von Frey method to measure mechanosensitivity 10
mice were individually placed into plexiglass chambers sitting atop a wire mesh stand (IITC Life
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Science Inc., CA) and allowed to acclimate to the environment for 30 minutes. From underneath
a mesh floor Von Frey filaments were applied perpendicularly to the plantar surface of the hind
paw only when the animal had all four paws resting on the floor. Responses were recorded in a
treatment blind manner, with a response considered positive when nociceptive behavior (paw
licking, shaking, or withdrawal) was observed immediately after application. The mice were
consecutively tested for a filament size, with application of the filament presented five times
before moving on to a filament size of higher force. Noxious response was recorded as three
positive responses out of five stimuli by a designated filament.

Water Avoidance Stress (WAS)
Individual mice were placed on a 4 cm x 5.5 cm platform situated in an 18.4 cm x 26 cm pool
filled with room temperature tap water to 1 cm below the top of the platform. WAS was
performed on Piezo2wt and Piezo2cKO between 09:00 and 12:00 for one hour on four consecutive
days. Control animals from both genotypes were brought into the same environment where WAS
took place, but remained in their cages. WAS and control animals were grouped and caged
separately according to treatment group. Baseline Von Frey testing was completed prior to
exposure stress and again on day four of WAS protocol for both control and treatment animals.

Gait Assay
To assess proprioception in mice an assay examining gait and stride length was performed

60

.

Regular printing paper was placed under a rectangular chamber with a dimension of 50 cm (L) x
5.5 cm (W) x 15.5 cm (H). Hind paws of mice were gently painted with water-based dye. Each
animal was placed at one end of the chamber and allowed to freely walk to the other end. The
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stride length was defined as the distance between the adjacent footprints from the same hind paw
measured from toe to toe. The stride length from the same animal was averaged as one number to
be included in the statistical analysis.

Immunohistochemistry
After fixation with 4% paraformaldehyde, explanted DRGs were incubated in 20% sucrose
overnight at 4 ℃ for cryoprotection. Embedded in OCT cryostat medium (Tissue Tek) DRGs
were sectioned at 10 µm thickness and placed on a gelatin-coated slide. The tissue sections were
processed for on-slide immunostaining. The CGRP primary antibody (1:1000, Thermo Fisher
Scientific) was diluted in IHC buffer (0.3 % Triton X-100 in 0.1 M PBS, pH 7.4) containing 5 %
normal donkey serum (NDS) (Jackson ImmunoResearch, West Grove, PA) and applied to tissue
sections and incubated overnight at room temperature. Slide were then washed and incubated
with fluorophore-conjugated species-specific secondary antibody (1:500, Molecular Probes,
Eugene, OR) in IHC buffer containing 2% NDS at room temperature for 2 hours. After final
washing, slides were cover-slipped with Citifluor mounting medium (Citifluor Ltd., London)
then viewed and analyzed using a Zeiss fluorescent microscope. Neurons that showed a visible
nucleus and exhibited immunoreactivity significantly greater than the background were counted
as positive. Overall area of the DRG was also measured excluding areas without neurons and
with excessive nerve fibers. A ratio of positive cell counts to area was presented. Analysis was
accomplished with built-in Zeiss software.

Slot/Dot Blot
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DRGs were freshly explanted and homogenized for protein extraction in T-PER buffer (Thermo
Fisher Scientific) supplemented with protease inhibitor cocktail (P8340, 1:100, Sigma-Aldrich).
After centrifugation at 12,000 rpm for 20 min at 4 °C, the protein concentration in the
supernatant was determined using Bio-Rad BCA protein assay kit as reference for sample
loading. Samples were applied the nitrocellulose membrane through the slot blot apparatus then
treated with 5% non-fat dry milk in TBS-T blocking buffer to block non-specific sites. Primary
antibodies against CGRP (1:1000, anti-rabbit, Thermo Fisher Scientific) or housekeeping protein
b-actin (1:1000, anti-mouse, Sigma-Aldrich) were incubated overnight at 4 °C then treated with
species specific secondary antibody conjugated with horseradish peroxidase (HRP). Bands were
identified by enhanced chemiluminescence (ECL) using a BioRad ChemiDoc MP Imaging
System and analyzed by Image J.

Statistical Analysis
Data was analyzed using Prism. Comparison between control and experimental groups was made
by using ANOVA or t test (see Figure Legends for details). The results for each study were
presented as mean ± SE. Differences between means at a level of p≤0.05 were considered to be
significant.
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Figure 2. Experimental Design. A. Male and female Piezo2wt and Piezo2cKO mice were assessed
for GI function, body weight growth and colonic transit time, as well as somatic mechanical
sensitivity using von Frey testing. B. Due to sex-specific variations associated with conditional
Piezo knockout only male mice were used for WAS study and characterization of WAS-induced
variation in GI function and mechanosensitivity.
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Figure 3. Colonic Transit Design. Colonic transit was measured by evacuation time for a 3
mm-diameter glass bead inserted 3 cm into the distal colon by catheter. Animals were
immediately placed into a glass chamber for recovery and total transit time was measured
starting as soon as the catheter was removed and stopped when the bead was expelled.
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Figure 4. Von Frey Testing Design. Von Frey filaments were applied perpendicularly to the
plantar surface of the hind paw only when animals had all four paws resting on the floor.
Responses were recorded with a response considered positive when nociceptive behavior (paw
licking, shaking, or withdrawal) was observed immediately after application.
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Figure 5. Gait Assay Design. To assess further sensory perception animals were subjected to a
gait assay. Hind paws of mice were gently painted with water-based dye and individual animals
were placed at one end of a rectangular chamber and allowed to freely walk to the other end.
Stride length was defined as the distance between adjacent toe prints from the same hindpaw.
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Results
4.1 Piezo2 conditional knockout produced sex-specific GI dysfunction.
Deletion of Piezo2 from nociceptive neurons coexpressing Nav1.8 affected GI function
of female, but not male mice. No significant difference in body weight growth was observed for
male mice weighed between three and seven weeks (Figure 6A). Increased body weights were
observed for female Piezo2cKO mice weighed between three and seven weeks when compared to
female Piezo2wt mice of corresponding ages (Figure 6B). It is interesting that female Piezo2cKO
body weights began lower at week three then surpassed Piezo2wt at week 5 becoming most
divergent at that point in time (p<0.0001). Colonic transit time was assessed by measuring
evacuation time for a 3mm glass bead inserted 3cm into the distal colon. Figure 7 shows colonic
transit also demonstrated significant variation for females only, with Piezo2cKO female mice
showing longer transit times compared to Piezo2wt female mice (p<0.05). Male mice had no
significant difference in transit time.

4.2 Piezo2 conditional knockout produced sex-specific altered response to somatic
mechanical stimuli.
Measurement of somatic mechanical sensitivity using von Frey testing revealed further
sexual dimorphism of Piezo2. Male mice only demonstrated significant difference in somatic
mechanical sensitivity at 0.16 gram (g) filament size (p<0.0001), within the innocuous range
(Figure 8A). No other significant difference in sensitivity was observed when comparing male
Piezo2wt and Piezo2cKO. For female mice, Piezo2cKO animals displayed hyposensitivity in
response to von Frey filaments throughout the innocuous stimulus range (p<0.0001 at 0.04g and
0.16g; p<0.01 at 0.4g) when compared to the responses of female Piezo2wt mice (Figure 8B).
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4.3 Piezo2 conditional knockout attenuated WAS-induced somatic mechanical
hypersensitivity in male mice.
Following a four-day course of WAS for 1 hour/day, Piezo2cKO was shown to attenuate
WAS-induced somatic hypersensitivity as only Piezo2wt mice developed somatic
hypersensitivity. Assessed by response to von Frey filament application to the hind paw,
Piezo2wt WAS mice demonstrated decreased threshold for withdrawal. The mechanical response
curve for Piezo2wt WAS shifted up and to the left indicating stimulus was perceived as allodynic
where previously innocuous and hyperalgesic where previously nociceptive (p<0.0001) (Figure
9). Piezo2cKO WAS mice did not develop hypersensitivity to mechanical stimuli displaying only
a slight response difference when compared to controls which may be attributed to hyperactivity
observed in these animals. Comparing the Piezo2wt WAS and Piezo2cKO WAS response curves,
there was significantly reduced threshold for Piezo2wt WAS within the innocuous range of 0.020.07gram (p<0.001-p<0.0001) where Piezo2wt WAS animals reached noxious response at 0.16g
and Piezo2cKO WAS reached at 0.6g (consistent with Piezo2cKO control).

4.4 Piezo2 conditional knockout exaggerated WAS-induced reduction in GI transit
Colonic transit time increased for both Piezo2wt WAS and Piezo2cKO WAS when
compared to control groups. Figure 10 shows the average transit time for Piezo2wt WAS to be
about 3 minutes 30 seconds compared to wild type controls at just over 2 minutes (p<0.01). For
Piezo2cKO WAS, average transit time increased to almost 5 minutes compared to just over 2
minutes for controls (p<0.001). Comparing Piezo2wt WAS and Piezo2cKO WAS, knockout
animals had an exaggerated decrease in colonic transit (p<0.01) an indicator of possible
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decreased colonic mechanical sensitivity during peristalsis due to the knockout. Transit time for
control animals from both groups reflect baseline numbers seen in Figure 7.

4.5 Piezo2 conditional knockout attenuated WAS-induced increases in CGRP expression in
DRG.
Slot blot and IHC results indicate Piezo2 knockout attenuated WAS-induced increases in
CGRP expression in DRGs (Figures 11 and 12). WAS induced higher levels of CGRP
expression in Piezo2wt mice. Figure 11A provides examples of sectioned DRG demonstrating
more positively stained neurons for CGRP in Piezo2wt WAS DRG compared to both Piezo2wt
control and Piezo2cKO WAS. Figure 11B shows WAS increased CGRP expression by two-fold
(p<0.001) for Piezo2wt mice. WAS also increased CGRP expression for Piezo2cKO mice, but to a
much less extent which proved not to be statistically significant. Comparing Piezo2wt WAS and
Piezo2cKO WAS animals there was roughly a one-and-a-half-fold difference in CGRP levels
(p<0.001). Figure 12 shows Slot Blot results consistent with IHC. Piezo2wt WAS DRG showed
increased CGRP expression when compared to Piezo2wt control (p<0.01). Again, there was no
significant difference in CGRP expression comparing Piezo2cKO WAS and Piezo2cKO control.
CGRP expression in Piezo2wt WAS DRG was also significantly greater than that of Piezo2cKO
WAS DRG (p<0.01).

4.6 Gait assay to characterize the effects of Piezo2 conditional knockout on WAS-induced
sensory dysfunction
Gait assay results revealed the average stride length for each of the Piezo2wt WAS
animals to be significantly shorter (p<0.05) and more erratic compared to Piezo2wt control
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animals (Figure 13 A and B). Piezo2cKO WAS animals also demonstrated slightly shorter stride
lengths, though not significantly different when compared to Piezo2cKO controls (Figure 13 A
and B) and WAS did not induce erratic gait for Piezo2cKO mice. Comparison of stride lengths
between Piezo2wt and Piezo2cKO controls also showed no statistically significant difference,
indicating no effect of the conditional knockout on sensory perception by this measure at
baseline.
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Figure 6. Body weight growth of male and female mice. A. Piezo2cKO had no significant effect
on male body weight growth. Piezo2wt n=13, Piezo2cKO n=17. B. Piezo2cKO female mice had
greater body weight growth than Piezo2wt female mice at corresponding ages. Piezo2wt n=10,
Piezo2cKO n=12. Two-way ANOVA. **, p<0.01; ****, p<0.0001.
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Figure 7. Male and Female Colonic Transit Time. Effect of conditional knockout on colonic
transit time was measured for both male and female mice by inserting a 3mm glass bead 3cm
into the distal colon and recording evacuation time. Piezo2cKO did not affect colonic transit time
in male mice. Female Piezo2cKO mice had significantly longer colonic transit times compared to
female Piezo2wt mice. Male Piezo2wt n=7 and Piezo2cKO n=15. Female Piezo2wt n=6, Piezo2cKO
n=7. Unpaired t test. *p<0.05.
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Figure 8. Male and Female Somatic Sensory Response to von Frey Testing. Baseline hind
paw withdrawal responses to von Frey filaments were measured for male and female mice.
Graphs display innocuous and noxious somatic mechanical stimuli, with noxious stimuli reported
as three out of five positive responses. A. Male Piezo2wt and Piezo2cKO mice demonstrated no
significant variation in response to mechanical stimulation except at 0.16g filament. B. Female
Piezo2cKO resulted in significant mechanical hyposensitivity to innocuous stimulation. Male
Piezo2wt n=11 and Piezo2cKO n=8. Female Piezo2wt n=5 and Piezo2cKO n=5. Two-way ANOVA.
**, p<0.01; ****, p<0.0001
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Figure 9. Effect of WAS on Somatic Sensory Response to von Frey Testing. Somatic
mechanical hypersensitivity developed in Piezo2wt WAS animals shifting the stimulus response
curve up and to the left. No significant change was observed for Piezo2cKO WAS mice compared
to Piezo2cKO controls. Piezo2wtCon n=11, Piezo2cKOCon n=8, Piezo2wtWAS n=5, Piezo2wtWAS
n=5. Two-way ANOVA. **, p<0.01; ***, p<0.001; ****, p<0.0001.
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Figure 10. Effect of WAS on Colonic Transit Time. Colonic transit was measured for male
Piezo2wt and Piezo2cKO control and WAS mice. WAS significantly increased colonic transit time
in both genotypes with Piezo2cKO WAS appearing to have exaggerated reduction in colonic
transit. Piezo2wtCon n=7, Piezo2wtWAS n=5, Piezo2cKOCon=15, Piezo2cKOWAS n=5. One-way
ANOVA Newman-Keuls Multiple Comparison Test **, p<0.01; ***, p<0.001
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Figure 11. Effect of WAS on CGRP protein expression in DRG neurons,
immunohistochemistry (IHC). A. CGRP immunoreactivity, arrows indicate examples of
positive neurons. B. Comparison of CGRP expression presented as fold change for Piezo2wt and
Piezo2cKO control and WAS mice. Piezo2 knockout attenuated WAS-induced increases in CGRP
expression in DRG. Results were obtained using 2-3 DRGs from each of the two animals per
experimental group. One-way ANOVA Newman-Keuls Multiple Comparison Test ***,
p<0.001; ns, not significant.
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Figure 12. Effect of WAS on CGRP protein expression in DRG neurons, Slot Blot. A. Slot
Blot of age-matched Piezo2wt and Piezo2cKO WAS and controls. Relative intensity of CGRP in
DRG using β-actin housekeeping gene. B. Piezo2wt WAS showed a significant increase in CGRP
expression compared to Piezo2wt Control and Piezo2cKO WAS. Piezo2 knockout attenuated
WAS-induced increases in CGRP expression in DRG. Results are shown for three animals from
each group. One-way ANOVA Newman-Keuls Multiple Comparison Test **, p<0.01.
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Figure 13. Effect of WAS on Gait Assay. A. Representative images of gait assay demonstrating
stride lengths and gait patterns. B. Presentation of average stride length per animal, Piezo2wt
WAS mice displayed significantly shorter stride lengths and more erratic gait patterns compared
to Piezo2wt controls. Piezo2cKO WAS mice also displayed shorter stride lengths, though not
statistically significant compared to Piezo2cKO controls. Piezo2wtCon n=8, Piezo2wtWAS n=5,
Piezo2cKOCon=8, Piezo2cKOWAS n=5. One-way ANOVA Newman-Keuls Multiple Comparison
Test *, p<0.05.
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Discussion

IBS is a common and chronic functional GI disorder characterized by visceral pain and
hypersensitivity. The pathophysiology of IBS is complex with visceral hypersensitivity, altered
bowel motility, neurotransmitter imbalance, and psychological factors all playing a role. The
spinal cord and DRG are critically involved in the pain transmission pathway. Physiological pain
is initiated by sensory nociceptors innervating peripheral organs and activated by noxious stimuli
81

. Noxious mechanical stimuli are converted into voltage changes via ionic transducers that

generate and propagate action potentials in DRG nerves that then relay signals to the CNS via the
dorsal horn of the spinal cord. In diseases involving pain such as IBS, nociceptive neurons can
demonstrate sensitization via maladaptive changes in DRG cell bodies and in their axons; these
changes result in hypersensitivity and hyperexcitability of sensory neurons 8. Recognizing
mechanosensitive Piezo2 ion channel expression in pain sensing primary afferents, this study
aimed to characterize the role of Piezo2 in stress-induced GI dysfunction and somatic pain
hypersensitivity.
In this study, baseline characterization of mechanical response and GI function reveals
Piezo2 conditional deletion results in a sex-differential impact on both parameters. Piezo2cKO is
shown to facilitate body weight growth in female but not male mice, decrease colonic transit in
female but not male mice, and cause robust mechanical hyposensitivity to innocuous stimulation
in female mice but less in male mice. This illusive finding suggests female mice rely more
heavily on Piezo2 for homeostatic mechanosensation. Due to this, female mice were not used
beyond baseline characterization in this study.
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Piezo2 is observed to mediate the development of somatic hypersensitivity in male mice
exposed to WAS. Only Piezo2wt WAS mice exhibited allodynic and hyperalgesic nociceptive
behavior in response to von Frey filament stimulation of hind paw. Hind paw stimulus was
perceived as allodynic at previously innocuous ranges and hyperalgesic during noxious stimulus.
WAS also alters further sensory perception examined by gait assay. Here, WAS caused
significantly shorter stride lengths and more erratic steps in Piezo2wt mice. Although there is no
statistically significant difference in sensory activity between Piezo2cKO control and Piezo2cKO
WAS mice, mean stride lengths for Piezo2cKO WAS mice were shorter than those of Piezo2cKO
control mice. Furthermore, Piezo2cKO appears to prevent WAS-induced erratic gait patterns seen
with Piezo2wt WAS mice. Whilst our available gait assay data only shows statistical significance
between Piezo2wt and Piezo2wt WAS, data more animals will be used to increase the sample size
to confirm the findings.
Using a stress-induced model of IBS, colonic transit time for both WAS groups
lengthened indicating decreased GI motility, specifically in the distal colon. The greater colonic
transit time for both WAS groups indicates the possibility of IBS-C like symptoms induced by
WAS and exacerbated when Piezo2 is absent from nociceptive neurons. Along with visceral
hypersensitivity, altered bowel function is another characteristic of IBS. Törnblom et al.
examined colonic transit time for a total of 359 IBS patients and found delayed colonic transit for
5% of patients studied 77. Findings from the present study reinforce the involvement of the gutbrain axis in IBS; with enhanced sympathetic regulation of GI motility causing slowed GI transit
and/or sensory neurogenic input to the colon from intrinsic/extrinsic nerves possibly playing a
role. Gil et al. investigated whether sympathetic nervous system exacerbation is relevant in a rat
model of stress-induced IBS by applying alpha1 and alpha2-adrenergic agonists and reported
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altered water content in the animal’s fecal output, a consistent maker for constipation or diarrhea
seen in IBS 35. Further studies will be performed to characterize colonic painful responses to
CRD and assess colonic mechanical sensitivity in Piezo2wt and Piezo2cKO mice subjected to
WAS.
Previous animal studies utilizing WAS have shown stress-induced increases in CGRP
release in the colon contributing to visceral hypersensitivity in mice 72. Here, CGRP expression
in DRG increases significantly for Piezo2wt WAS, but not for Piezo2cKO WAS mice. Slot Blot
results reveal Piezo2 may play a role in mediating CGRP release from DRG in WAS exposed
animals. Similarly, IHC shows immunoreactivity for CGRP in Piezo2wt WAS DRG is
significantly higher compared to Piezo2wt control and Piezo2cKO WAS DRG. It is important to
note that sensory afferents for the colon and hind paw project to different spinal segments.
Rather than global DRG harvesting and processing, future study will explant DRG from specific
spinal segments (colon: T12-L2, rectum: L6-S1, and hind paw: L4) to better tie biochemical
analysis to visceral and somatic hypersensitivity.
This study characterized the role of Piezo2 in nociceptive sensory afferents as they relate
to stress-induced GI dysfunction and somatic hypersensitivity, further study is necessary to
identify mechanisms. In continued study, it will also be important to validate and identify the
reduction of Piezo2 in DRG nociceptive neurons of Piezo2cKO mice recognizing the coexpression
of Piezo2 and Nav1.8 in other structures such as the heart. Several studies have linked Piezo2 to
mechanical pain and pathological hypersensitivity. Piezo2 is known to mediate somatic
mechanical allodynia, mice lacking Piezo2 56 and humans with Piezo2 loss of function 74 do not
develop somatic mechanical allodynia. During inflammation Piezo2 channels in the PNS have
been shown to be potentiated downstream of proinflammatory compounds like bradykinin 26.
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Such changes can sensitize mechanotransduction in nociceptors making them easier to activate
and/or making their responses to mechanical stimuli last longer 26,75. Recent studies have also
demonstrated upregulation of ion channel protein expression in colonic nociceptive afferent
neurons in DRG following induced visceral hypersensitivity 22. Furthermore, Bai et al. has
presented Piezo2 as a candidate biomarker of visceral hypersensitivity in IBS after demonstrating
increased expression of Piezo2 in the colon with significant correlation between Piezo2
expression and visceral sensitivity 6. Ion channels expressed in sensory neurons, including
TRPA1, TRPV1, and Nav1.7 have been suggested as targets for therapeutics to alleviate pain 8,17.
Peizo2’s role in visceral and somatic hypersensitivity present a unique target for IBS research.
The study of this mechanosensitive ion channel located in nociceptive neurons can help
conceptualize the pathophysiology of IBS visceral hypersensitivity as it has been shown here and
in other studies to mediate pain sensation.
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